These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9441094)

  • 41. Ethambutol in paediatric tuberculosis: aspects of ethambutol serum concentration, efficacy and toxicity in children.
    Thee S; Detjen A; Quarcoo D; Wahn U; Magdorf K
    Int J Tuberc Lung Dis; 2007 Sep; 11(9):965-71. PubMed ID: 17705973
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New approaches to the treatment of latent tuberculosis.
    Sterling TR
    Semin Respir Crit Care Med; 2008 Oct; 29(5):532-41. PubMed ID: 18810686
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Older antibiotic gains new respect as potent treatment for tuberculosis. Rifapentine is already approved for use with humans.
    Nuermberger E
    Home Healthc Nurse; 2008 Apr; 26(4):204-5. PubMed ID: 18408506
    [No Abstract]   [Full Text] [Related]  

  • 44. [Controlled clinical trial on efficacy of 5-month regimens and whole course intermittent 6-month regimens in treating bacillary pulmonary tuberculosis].
    Chu N; Yan B; Zhu L
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jul; 21(7):388-91. PubMed ID: 11326873
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rifapentine.
    Tuberculosis (Edinb); 2008 Mar; 88(2):155-8. PubMed ID: 18486059
    [No Abstract]   [Full Text] [Related]  

  • 47. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosis.
    Cohen K; van Cutsem G; Boulle A; McIlleron H; Goemaere E; Smith PJ; Maartens G
    J Antimicrob Chemother; 2008 Feb; 61(2):389-93. PubMed ID: 18096560
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preliminary pharmacokinetic study of repeated doses of rifampin and rifapentine in guinea pigs.
    Dutta NK; Alsultan A; Peloquin CA; Karakousis PC
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1535-7. PubMed ID: 23295923
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics of rifapentine in patients with varying degrees of hepatic dysfunction.
    Keung AC; Eller MG; Weir SJ
    J Clin Pharmacol; 1998 Jun; 38(6):517-24. PubMed ID: 9650541
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extra-pulmonary and pulmonary tuberculosis in Hong Kong.
    Noertjojo K; Tam CM; Chan SL; Chan-Yeung MM
    Int J Tuberc Lung Dis; 2002 Oct; 6(10):879-86. PubMed ID: 12365574
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis.
    Hoekstra M; Haagsma C; Neef C; Proost J; Knuif A; van de Laar M
    J Rheumatol; 2004 Apr; 31(4):645-8. PubMed ID: 15088287
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Single-dose pharmacokinetics of rifapentine in elderly men.
    Keung AC; Eller MG; Weir SJ
    Pharm Res; 1998 Aug; 15(8):1286-91. PubMed ID: 9706063
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rifapentine pharmacokinetics in adolescents.
    Marshall JD; Abdel-Rahman S; Johnson K; Kauffman RE; Kearns GL
    Pediatr Infect Dis J; 1999 Oct; 18(10):882-8. PubMed ID: 10530584
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An update on the use of rifapentine for tuberculosis therapy.
    Chan JG; Bai X; Traini D
    Expert Opin Drug Deliv; 2014 Mar; 11(3):421-31. PubMed ID: 24397259
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-performance liquid chromatography assay of rifapentine in human serum.
    He X; Wang J; Liu X; Chen X
    J Chromatogr B Biomed Appl; 1996 Jun; 681(2):412-5. PubMed ID: 8811456
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical and pharmacological hallmarks of rifapentine's use in diabetes patients with active and latent tuberculosis: do we know enough?
    Zheng C; Hu X; Zhao L; Hu M; Gao F
    Drug Des Devel Ther; 2017; 11():2957-2968. PubMed ID: 29066867
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Single-dose pharmacokinetics of rifapentine in women.
    Keung AC; Eller MG; Weir SJ
    J Pharmacokinet Biopharm; 1998 Feb; 26(1):75-85. PubMed ID: 9773393
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rifapentine access in Europe: growing concerns over key tuberculosis treatment component.
    Guglielmetti L; Günther G; Leu C; Cirillo D; Duarte R; Garcia-Basteiro AL; Goletti D; Jankovic M; Kuksa L; Maurer FP; Méchaï F; Tiberi S; van Leth F; Veziris N; Lange C; ;
    Eur Respir J; 2022 May; 59(5):. PubMed ID: 35589114
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Decreased plasma rifapentine concentrations associated with AADAC single nucleotide polymorphism in adults with tuberculosis.
    Weiner M; Gelfond J; Johnson-Pais TL; Engle M; Johnson JL; Whitworth WC; Bliven-Sizemore E; Nsubuga P; Dorman SE; Savic R;
    J Antimicrob Chemother; 2021 Feb; 76(3):582-586. PubMed ID: 33374006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.